We cannot exclude that other factors were impacting insulin signaling and receptor activity; however, we attempted to exclude cases with chronic illnesses that may have influenced incretin hormone release, insulin, or incretin signaling in organs of interest or significant disease or therapy that may have led to insulin resistance. This evidence concerns the gene GIP and Insulin resistance.